These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7494918)

  • 1. Spontaneous haemothorax as a complication of anti-coagulation following coronary angioplasty.
    Robinson NM; Thomas MR; Jewitt DE
    Respir Med; 1995 Oct; 89(9):629-30. PubMed ID: 7494918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemothorax--a complication of anticoagulation for suspected pulmonary embolism.
    Morecroft JA; Lea RE
    Br J Clin Pract; 1988 May; 42(5):217-8. PubMed ID: 3214645
    [No Abstract]   [Full Text] [Related]  

  • 3. Massive hemothorax complicating heparin anticoagulation for pulmonary embolus.
    Rostand RA; Feldman RL; Block ER
    South Med J; 1977 Sep; 70(9):1128-30. PubMed ID: 897742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open design, multicentre, randomized trial of percutaneous transluminal coronary angioplasty versus stenting, with a heparin-coated stent, of totally occluded coronary arteries: rationale, trial design and baseline patient characteristics. Total Occlusion Study of Canada (TOSCA) Investigators.
    Dzavik V; Carere RG; Teo KK; Knudtson ML; Marquis JF; Buller CE
    Can J Cardiol; 1998 Jun; 14(6):825-32. PubMed ID: 9676168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of hemostasis, endogenous fibrinolysis, platelet activation and endothelins after percutaneous transluminal coronary angioplasty in patients with stable angina.
    Borries M; Heins M; Fischer Y; Stiegler H; Peters A; Reinauer H; Schoebel FC; Strauer BE; Leschke M
    J Am Coll Cardiol; 1999 Aug; 34(2):486-93. PubMed ID: 10440163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of recombinant hirudin (CGP 39 393) versus heparin in patients with stable angina undergoing coronary angioplasty.
    van den Bos AA; Deckers JW; Heyndrickx GR; Laarman GJ; Suryapranata H; Zijlstra F; Close P; Rijnierse JJ; Buller HR; Serruys PW
    Circulation; 1993 Nov; 88(5 Pt 1):2058-66. PubMed ID: 8222099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated clotting times in acute coronary syndromes and percutaneous transluminal coronary angioplasty.
    Wilson JM; Dougherty KG; Ellis KO; Ferguson JJ
    Cathet Cardiovasc Diagn; 1995 Jan; 34(1):1-5. PubMed ID: 7728844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunctive intracoronary infusion of antithrombin III during percutaneous transluminal coronary angioplasty. Results of a prospective, randomized trial.
    Schächinger V; Allert M; Kasper W; Just H; Vach W; Zeiher AM
    Circulation; 1994 Nov; 90(5):2258-66. PubMed ID: 7955182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty. Results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial). Reduction of Restenosis After PTCA, Early Administration of Reviparin in a Double-Blind Unfractionated Heparin and Placebo-Controlled Evaluation.
    Karsch KR; Preisack MB; Baildon R; Eschenfelder V; Foley D; Garcia EJ; Kaltenbach M; Meisner C; Selbmann HK; Serruys PW; Shiu MF; Sujatta M; Bonan R
    J Am Coll Cardiol; 1996 Nov; 28(6):1437-43. PubMed ID: 8917255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New aspects of blood coagulation inhibitory therapy within the scope of percutaneous transluminal coronary angioplasty (PTCA)].
    Schächinger V; Zeiher AM
    Z Kardiol; 1995 Sep; 84(9):651-67. PubMed ID: 8525667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory monitoring of heparin and the combination of heparin and the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3) in patients undergoing percutaneous transluminal coronary angioplasty (PTCA).
    Zahn R; Haubelt H; Bechtloff S; Schneider S; Frilling B; Rustige J; Marsalek P; Seidl K; Senges J; Hellstern P
    Herz; 2003 Aug; 28(5):445-52. PubMed ID: 12928744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ancrod infusion for anticoagulation during and after PTCA in a patient with heparin-induced thrombocytopenia.
    Moore JA; Burket MW; Puri S; Temesy-Armos P; Lachant N; Skeel R
    Cathet Cardiovasc Diagn; 1994 Jul; 32(3):286-7. PubMed ID: 7954782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute myocardial infarction during coronary angioplasty associated with heparin-induced thrombocytopenia.
    Gupta BK; Savage MP; Brest AN
    Cathet Cardiovasc Diagn; 1995 May; 35(1):42-6. PubMed ID: 7614539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence, outcome and prediction of early clinical events following percutaneous transluminal coronary angioplasty. A comparison between treatment with reviparin and unfractionated heparin/placebo (results of a substudy of the REDUCE trial).
    Preisack MB; Bonan R; Meisner C; Eschenfelder V; Karsch KR
    Eur Heart J; 1998 Aug; 19(8):1232-8. PubMed ID: 9740345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ancrod for coronary angioplasty.
    Pothoulakis AJ; Neerukonda SK; Ansel G; Jantz RD
    Tex Heart Inst J; 1995; 22(4):342-6. PubMed ID: 8605439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal heparinization in coronary angioplasty--how much heparin is really warranted?
    Kaluski E; Krakover R; Cotter G; Hendler A; Zyssman I; Milovanov O; Blatt A; Zimmerman E; Goldstein E; Nahman V; Vered Z
    Am J Cardiol; 2000 Apr; 85(8):953-6. PubMed ID: 10760333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombin III supplementation for patients undergoing PTCA for unstable angina pectoris. A controlled randomized double-blind pilot study.
    Grip L; Blombäck M; Egberg N; Olsson A; Svane B; Velander M
    Eur Heart J; 1997 Mar; 18(3):443-9. PubMed ID: 9076381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse cardiac outcomes after noncardiac surgery in patients with prior percutaneous transluminal coronary angioplasty.
    Posner KL; Van Norman GA; Chan V
    Anesth Analg; 1999 Sep; 89(3):553-60. PubMed ID: 10475280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of low dose heparin in elective coronary angioplasty.
    Koch KT; Piek JJ; de Winter RJ; David GK; Mulder K; Tijssen JG; Lie KI
    Heart; 1997 Jun; 77(6):517-22. PubMed ID: 9227294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new manifestation and treatment alternative for heparin-induced thrombosis.
    Dieck JA; Rizo-Patron C; Unisa A; Mathur V; Massumi GA
    Chest; 1990 Dec; 98(6):1524-6. PubMed ID: 2123154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.